Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

GenSight Biologics S.A. - Filing #879715

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
25,000 EUR
207,000 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
3,285,000 EUR
3,602,000 EUR
Current assets
53,363,000 EUR
43,759,000 EUR
Non-current liabilities
18,417,000 EUR
18,489,000 EUR
Current liabilities
22,242,000 EUR
17,123,000 EUR
Revenue
5,276,000 EUR
4,394,000 EUR
Profit (loss)
28,617,000 EUR
28,617,000 EUR
34,015,000 EUR
34,015,000 EUR
Comprehensive income
28,617,000 EUR
28,824,000 EUR
207,000 EUR
33,684,000 EUR
331,000 EUR
34,015,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.